Alector, Inc. (ALEC) Corporate Subsidiaries
Alector, Inc. (ALEC) is a publicly traded company on the Nasdaq, categorized under SIC 2836 (Biological Products, (No Diagnostic Substances)). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: ALEC
CIK: 1653087
Exchange: Nasdaq
SIC 2836: Biological Products, (No Diagnostic Substances)
Fiscal Year End: 12/31
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Ernst & Young LLP
Auditor SinceSince 12/31/2017 12:00:00 AM
Lead Engagement PartnerYogesh Ransing
Audit LocationSan Mateo, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 424B5 | 2026-10-16 | — | 424B5 | 0001193125-26-424215 | View SEC Doc Filr Page |
| 8-K | 2026-10-16 | 2026-10-15 | 8-K | 0001193125-26-424204 | View SEC Doc Filr Page |
| FWP | 2026-10-16 | — | FWP | 0001193125-26-423393 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-13 | 4 | 0001193125-26-422869 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-13 | 4 | 0001193125-26-422867 | View SEC Doc Filr Page |
| 4 | 2026-10-15 | 2026-10-14 | 4 | 0001193125-26-422868 | View SEC Doc Filr Page |
| 8-K | 2026-10-14 | 2026-10-13 | 8-K | 0001193125-26-421080 | View SEC Doc Filr Page |
| 8-K | 2026-10-05 | 2026-09-30 | 8-K | 0001193125-26-413090 | View SEC Doc Filr Page |
| SCHEDULE 13G | 2026-09-18 | — | SCHEDULE 13G Filing | 0000921895-26-002587 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-02 | 4 | 0001193125-26-383858 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | 4 | 0001193125-26-383856 | View SEC Doc Filr Page |
| 4 | 2026-09-04 | 2026-09-03 | 4 | 0001193125-26-383857 | View SEC Doc Filr Page |
| 144 | 2026-09-04 | — | 144 Filing | 0001950047-26-009118 | View SEC Doc Filr Page |
| 144 | 2026-09-02 | — | 144 Filing | 0001950047-26-009039 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001193125-26-379023 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001193125-26-379022 | View SEC Doc Filr Page |
| 144 | 2026-09-01 | — | 144 Filing | 0001193125-26-379020 | View SEC Doc Filr Page |
| 4 | 2026-08-21 | 2026-08-19 | 4 | 0001193125-26-361376 | View SEC Doc Filr Page |
| 10-Q | 2026-08-06 | 2026-06-30 | 10-Q | 0001193125-26-338052 | View SEC Doc Filr Page |
| 8-K | 2026-08-06 | 2026-08-06 | 8-K | 0001193125-26-338008 | View SEC Doc Filr Page |
| 4 | 2026-07-09 | 2026-07-09 | 4 | 0001193125-26-299678 | View SEC Doc Filr Page |
| 8-K | 2026-07-08 | 2026-07-06 | 8-K | 0001193125-26-298526 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-17 | 4 | 0001193125-26-274134 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-17 | 4 | 0001193125-26-274128 | View SEC Doc Filr Page |
| 4 | 2026-06-17 | 2026-06-17 | 4 | 0001193125-26-274131 | View SEC Doc Filr Page |